Huma-Folacid (Folic Acid)

Huma-Folacid is used to address folate needs in various health contexts.

• Prevention of neural tube defects in women of childbearing age, especially when taken before conception and during early pregnancy.
• Treatment of folate deficiency resulting from inadequate dietary intake, malabsorption syndromes, or increased physiological demand such as pregnancy.
• Support for patients receiving medications that interfere with folate metabolism, including certain antiepileptic drugs, methotrexate, and trimethoprim.
• Adjunctive therapy for megaloblastic anemia or other anemia types linked to folate deficiency, helping to restore normal red blood cell production.
• General supplementation to maintain adequate folate status and normal homocysteine metabolism in the adult population.

• Folic acid is a synthetic oxidized form of the naturally occurring vitamin B9. After oral absorption, it is reduced to tetrahydrofolate, which serves as a carrier of one‑carbon units in various biochemical reactions. These one‑carbon transfers are essential for the synthesis of purine nucleotides and thymidylate, enabling DNA replication and repair, as well as for methylation processes that regulate gene expression and amino acid metabolism.

Oral folic acid is generally well tolerated, but some individuals may experience adverse reactions ranging from mild, transient symptoms to rare, serious events.

Common

• Nausea or mild gastrointestinal upset, such as stomach discomfort or bloating.
• Decreased appetite or feeling of fullness.
• Transient headache that resolves without treatment.
• Skin rash, pruritus, or mild itching at the site of contact.
• Mild dizziness or light‑headedness, especially when standing quickly.

Serious

• Allergic reactions including facial, lip, tongue, or throat swelling that may impair breathing.
• Severe cutaneous adverse reactions, for example Stevens‑Johnson syndrome or toxic epidermal necrolysis.
• Unexplained bleeding, bruising, or hematologic abnormalities.
• Rapid or irregular heartbeat, palpitations, or chest discomfort.

When using Huma-Folacid, certain precautions should be considered to ensure safe and appropriate supplementation.

• Assess folate status before initiating supplementation, especially in individuals with known deficiency or increased requirements.
• Use caution in patients with renal or hepatic impairment, as altered metabolism may affect folate handling.
• Monitor for signs of hypersensitivity, and discontinue use if an allergic reaction occurs.
• Discuss with a healthcare professional before combining with high‑dose vitamin regimens or other B‑complex supplements.
• Pregnant or breastfeeding women should follow recommended prenatal guidelines and consult a clinician.
• Individuals with a history of seizure disorders should be aware that high folate levels may influence seizure threshold.

Folic acid can interact with certain medications or nutrients, potentially altering its effectiveness or that of the co‑administered agent.

Avoid

• Concurrent use of high‑dose methotrexate without folate rescue, as folic acid may reduce the drug’s therapeutic effect.
• Combining with antimetabolite chemotherapy agents (e.g., pemetrexed) where folate supplementation can diminish anticancer activity.

Use with caution

• Antiepileptic drugs such as phenytoin, carbamazepine, or phenobarbital, which may increase folate requirements.
• Trimethoprim‑sulfamethoxazole, which can impair folate metabolism.
• Vitamin B12 deficiency, where high folic acid may mask hematologic signs without correcting neurological deficits.
• Iron supplements, as large doses may compete for absorption pathways.